A Modified Protocol for Estimation of Insulin Sensitivity with the Minimal Model of Glucose Kinetics in Patients with Insulin-Dependent Diabetes*
- 1 June 1990
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 70 (6) , 1538-1549
- https://doi.org/10.1210/jcem-70-6-1538
Abstract
An exogenous insulin administration-modified, frequently sampled iv glucose tolerance test (FSIGT) for application in insulin-dependent diabetic patients (IDDM) to allow for estimation of insulin sensitivity (SI) and glucose effectiveness (SG) with Bergman''s minimal model of glucose kinetics was investigated. An insulin infusion protocol (either 4 or 8 mU/min.cntdot.kg from 20-25 min) was compared to the standard tolbutamide-modified (300 mg at 20 min) FSIGT in normal control subjects. SI and SG were not different for the insulin infusion-and tolbutamide-modified protocols [SI, 2.8 .+-. 0.4, 3.6 .+-. 0.6, and 2.5 .+-. 0.5 .times. 104 min1/(.+-./mL), respectively]. SI and SG were quantified in insulin-requiring newly diagnosed IDDM and in noninsulin-requiring IDDM in climical remission with the exogenous insulin adminstration protocol. Both SI and SG were reduced in newly diagnosed IDDM compared to normal controls (by 64% and 40%, respectively). SI was normalized in IDDM in clinical remission despite a continued poor insulin secretory response to both glucose and tolbutamide. Although SI was normal in patients in clinical remission, SG remained reduced (by 65%) compared to that in normal controls. In conclusion, our results demonstrate that modification of the FSIGT with the exogenous administration of insulin allows for estimation of insulin sensitivity and glucose effectiveness in IDDM patients. Comparison to the standard protocol in normal subjects suggests that this results in valid measurements of insulin sensitivity and glucose effectiveness. Results of the application of this protocol in IDDM were consistent with previous observations that insulin sensitivity is reduced in poorly controlled IDDM and normalized in well controlled patients. Glucose effectiveness was found to be reduced in all IDDM subjects regardless of the degree of control.This publication has 16 references indexed in Scilit:
- Assessment of Insulin Sensitivityin Vivo*Endocrine Reviews, 1985
- Insulin Sensitivity in Newly Diagnosed Type 1 Diabetics after Ketoacidosis and after Three Months of Insulin Therapy*Journal of Clinical Endocrinology & Metabolism, 1984
- Continuous Subcutaneous Insulin Infusion Therapy Decreases Insulin Resistance in Type 1 Diabetes*Journal of Clinical Endocrinology & Metabolism, 1984
- Insulin resistance in Type 1 (insulin-dependent) diabetes: dependence on plasma insulin concentrationDiabetologia, 1984
- Lack of in Vivo Insulin Resistance in Controlled Insulin-Dependent, Type I, Diabetic Patients*Journal of Clinical Endocrinology & Metabolism, 1984
- Insulin resistance in alloxan-diabetic dogs: Evidence for reversal following insulin therapyDiabetologia, 1983
- ACUTE TOLBUTAMIDE ADMINISTRATION ALONE OR COMBINED WITH INSULIN ENHANCES GLUCOSE INTAKE IN THE PERFUSED RAT HINDLIMBEndocrinology, 1982
- Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose.Journal of Clinical Investigation, 1981
- Improved colorimetric assay for glycosylated hemoglobin.Clinical Chemistry, 1981
- Quantitative estimation of insulin sensitivity.American Journal of Physiology-Endocrinology and Metabolism, 1979